Shenshi Technology - About the company
Shenshi Technology is a series C company based in Beijing (China), founded in 2019. It operates as a Developer of AI-driven platform and tools for scientific research and development. Shenshi Technology has raised $255M in funding from investors like Qiming Venture Partners, Source Code Capital and Baidu Venture Capital. The company has 155 active competitors, including 65 funded and 11 that have exited. Its top competitors include companies like Recursion Pharmaceuticals, Healx and XtalPi.
Company Details
Developer of AI-driven platform and tools for scientific research and development. The platform offers resources for accessing academic literature, managing research projects, and running code. It provides a unified environment connecting software and hardware resources. The platform supports data management, environment replication, and team collaboration. It facilitates structured data analysis for scientific applications across various disciplines.
- Website
- www.dp.tech
- Email ID
- *****@dp.tech
- Phone Number
- +86 **********
Key Metrics
Founded Year
2019
Location
Beijing, China
Stage
Series C
Total Funding
$255M in 8 rounds
Latest Funding Round
Investors
Ranked
19th among 155 active competitors
Employee Count
103 as on May 31, 2026
Similar Companies
Sign up to download Shenshi Technology's company profile
Shenshi Technology's funding and investors
Shenshi Technology has raised a total funding of $255M over 8 rounds. Its first funding round was on Jul 2020. Its latest funding round was a Series C round on Dec 24, 2025 for $*****. 5 investors participated in its latest round. Shenshi Technology has 24 institutional investors.
Here is the list of recent funding rounds of Shenshi Technology:
Filter this list
Filter this listDate of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Dec 24, 2025 | 1014472 | Series C | 3591513 | 2734955 | 2021100 | 8703515 |
Oct 15, 2024 | 6341293 | Series B | 5902451 | 7574490 | 3798441 | 9866278 |
Aug 19, 2023 | 2747720 | Series B | 5680672 | 8456288 | 4173444 |
Access funding benchmarks and valuations. Sign up today!View details of Shenshi Technology's funding rounds and investors
Shenshi Technology's founders and board of directors
Founder? Claim ProfileShenshi Technology's employee count trend
Shenshi Technology has 103 employees as of May 26. Here is Shenshi Technology's employee count trend over the years:
Uncover Shenshi Technology's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Shenshi Technology's Competitors and alternates
Top competitors of Shenshi Technology include Recursion Pharmaceuticals, Healx and XtalPi. Here is the list of Top 10 competitors of Shenshi Technology, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Recursion Pharmaceuticals 2013, New York (United States), Public | AI-enabled drug discovery and development platform for novel therapeutics | $452M | 72/100 | |
2nd |  Healx 2014, Cambridge (United Kingdom), Series C | AI-powered drug discovery platform to treat rare diseases | $115M | 69/100 | |
3rd |  XtalPi 2014, Cambridge (United States), Public | AI-based drug research and development company | $785M | 67/100 | |
4th |  Schrodinger 1990, New York City (United States), Acquired | Provider of a web-based simulation and modelling tool | $162M | 66/100 | |
5th |  METiS Therapeutics 2017, Cambridge (United States), Series B | Provider of an AI-assisted platform for drug discovery and development | $252M | 63/100 | |
6th |  Xaira 2023, San Francisco (United States), Series D | AI-enabled platform for drug discovery and development | $1B | 63/100 | |
7th |  Valo Health 2019, Boston (United States), Series B | AI-powered platform for drug discovery and development | $450M | 62/100 | |
8th |  In Silico 2014, Cambridge (United States), Public | AI-enabled bioinformatics platform for drug discovery and biomarker development | $510M | 62/100 | |
9th | Developer of reverse engineering technology for controlling aging | $13.5M | 62/100 | ||
10th |  Tandem AI 2021, New York (United States), Series A | AI-based drug discovery tool for researchers | $82M | 62/100 | |
19th |  Shenshi Technology 2019, Beijing (China), Series C | Developer of AI-driven platform and tools for scientific research and development | $255M | 58/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Shenshi Technology's competitors? Click here to see the top ones
Shenshi Technology's Investments and acquisitions
Shenshi Technology has made no investments or acquisitions yet.
News related to Shenshi Technology
Media has covered Shenshi Technology for 1 event in last 1 year.
•
DP Technology Secures $109.6M+ Series C Funding for AI-Driven Scientific DiscoveryPandaily•Dec 25, 2025•Lenovo, Shenshi Technology, DT Capital, SCMP and 3 others
•
•
•
•
•
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about Shenshi Technology
Explore our recently published companies
- StayWokeProperty - Cheras based, 2022 founded, Unfunded company
- Lyndung - Cyberjaya based, 2022 founded, Unfunded company
- NextGen Pilot - Kuala Lumpur based, 2024 founded, Unfunded company
- Okay Tasks - Klang based, 2024 founded, Unfunded company
- Cynco - Kuala Lumpur based, 2024 founded, Unfunded company
- Viucom - Shah Alam based, 2023 founded, Unfunded company
